Frontiers in Immunology · 2018 · 22 citations · 60 references
Life SciencesImmunologyInfectious DiseasesAdaptive ImmunityImmunology Of Infectious DiseasesInnate ImmunityAntigen RecognitionAntiviral ImmunityCell-mediated ImmunityNatural Killer Cell BiologyNatural Killer Cell FunctionNatural Killer Cell RegulationCellular Immune Response To VirusesHost Cell ReceptorsNatural Killer Cell Receptor Nkg2dNatural Killer Cell Receptor-ligand InteractionsNkg2d-mediated RecognitionReceptorsSteric ShieldingT Cell Receptors
The Ebola virus (EBOV) uses evasion mechanisms that directly interfere with host T-cell antiviral responses. By steric shielding of human leukocyte antigen class-1, the Ebola glycoprotein (GP) blocks interaction with T-cell receptors (TCRs), thus rendering T cells unable to attack virus-infected cells. It is likely that this mechanism could promote increased natural killer (NK) cell activity against GP-expressing cells by preventing the engagement of NK inhibitory receptors; however, we found that primary human NK cells were less reactive to GP-expressing HEK293T cells. This was manifested as reduced cytokine secretion, a reduction in NK degranulation, and decreased lysis of GP-expressing target cells. We also demonstrated reduced recognition of GP-expressing cells by recombinant NKG2D and NKp30 receptors. In accordance, we showed a reduced monoclonal antibody-based staining of NKG2D and NKp30 ligands on GP-expressing target cells. Trypsin digestion of the membrane-associated GP led to a recovery of the recognition of membrane-associated NKG2D and NKp30 ligands. We further showed that membrane-associated GP did not shield recognition by KIR2DL receptors; in accordance, GP expression by target cells significantly perturbed signal transduction through activating, but not through inhibitory, receptors. Our results suggest a novel evasion mechanism employed by the EBOV to specifically avoid the NK cell immune response.
60
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Klas Kärre, Hans Ljunggren, Gerald E. Piontek et al. · Nature · 1986 · 2.1K citations
Life Sciences, Immunology, Oncology +12
Veit Hornung, Simon Rothenfußer, Stefanie Britsch et al. · The Journal of Immunology · 2002 · 1.9K citations
Emergence of Zaire Ebola Virus Disease in Guinea
Sylvain Baize, Delphine Pannetier, Lisa Oestereich et al. · New England Journal of Medicine · 2014 · 1.4K citations · Full text
Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak
Stephen Gire, Augustine Goba, Kristian G. Andersen et al. · Science · 2014 · 1.3K citations · Full text